Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma

Detalles Bibliográficos
Autores principales: Saburi, Masuho, Ogata, Masao, Soga, Yasuhiro, Kondo, Yoshiyuki, Kurimoto, Ryo, Itani, Kazuhito, Kohno, Kazuhiro, Uchida, Hiroki, Nakayama, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187674/
https://www.ncbi.nlm.nih.gov/pubmed/32224561
http://dx.doi.org/10.3960/jslrt.19031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187674/
https://www.ncbi.nlm.nih.gov/pubmed/32224561
http://dx.doi.org/10.3960/jslrt.19031

Ejemplares similares